HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Sys. Review
Immunocytokines offer improved safety profiles compared to systemic cytokine therapy in cancer treatment
Newer cancer treatments may offer safer options for patients
This narrative review examines immunocytokines including IL-2, IL-12, and TNF-alpha based constructs for cancer treatment. The authors concl…
Newer versions of immune-boosting drugs may offer a safer way to treat cancer by reducing the severe side effects of older therapies.
Frontiers
Sep 29, 2026
Allergy & Immunology
Sys. Review
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection
Cytokine Therapies Show Potential for Treating Canine Cancers
This mini review synthesizes evidence on targeted cytokine delivery platforms, such as IL-12 and IFN-beta, in dogs with various spontaneous …
New research explores how targeted cytokine delivery systems can treat various cancers in dogs and provide data for future human cancer trea…
Frontiers
Jul 6, 2026